Skip to main content
Livermore
Livermore
ZHEN

Jade Biosciences, Inc.

JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001798749

No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Jade Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−1 vs. Q4 2021
Shares held
25.9M
+357.5K (+1.4%) vs. Q4 2021
Total value
$475.5M
+$173.9M (+57.7%) vs. Q4 2021
New holders
10
15 more added
Sold out
11
12 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 46 institutions
Q1 2021: 0 institutionsQ2 2021: 18 institutionsQ3 2021: 41 institutionsQ4 2021: 47 institutionsQ1 2022: 46 institutionsQ2 2022: 51 institutionsQ3 2022: 56 institutionsQ4 2022: 70 institutionsQ1 2023: 66 institutionsQ2 2023: 60 institutionsQ3 2023: 58 institutionsQ4 2023: 64 institutionsQ1 2024: 81 institutionsQ2 2024: 81 institutionsQ3 2024: 75 institutionsQ4 2024: 80 institutionsQ1 2025: 82 institutionsQ2 2025: 75 institutionsQ3 2025: 78 institutionsQ4 2025: 105 institutionsQ1 2026: 120 institutionsQ2 2026: 153 institutions
Value heldQ1 2022: $475.5M
Q1 2021: $0Q2 2021: $454.4MQ3 2021: $452.6MQ4 2021: $301.6MQ1 2022: $475.5MQ2 2022: $403.0MQ3 2022: $447.4MQ4 2022: $802.9MQ1 2023: $524.1MQ2 2023: $488.3MQ3 2023: $386.3MQ4 2023: $637.8MQ1 2024: $841.5MQ2 2024: $45.1MQ3 2024: $57.8MQ4 2024: $79.9MQ1 2025: $79.6MQ2 2025: $315.1MQ3 2025: $272.9MQ4 2025: $726.3MQ1 2026: $700.3MQ2 2026: $1.62B
Institutions holding JBIO and their total value by quarter
QuarterHoldersValue
Q2 2026153$1.62B
Q1 2026120$700.3M
Q4 2025105$726.3M
Q3 202578$272.9M
Q2 202575$315.1M
Q1 202582$79.6M
Q4 202480$79.9M
Q3 202475$57.8M
Q2 202481$45.1M
Q1 202481$841.5M
Q4 202364$637.8M
Q3 202358$386.3M
Q2 202360$488.3M
Q1 202366$524.1M
Q4 202270$802.9M
Q3 202256$447.4M
Q2 202251$403.0M
Q1 202246$475.5M
Q4 202147$301.6M
Q3 202141$452.6M
Q2 202118$454.4M
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q4 2021.

Institutions holding JBIO in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Ellevest, Inc.13$00.00%+13New
Daiwa Securities Group Inc.73$1.00K0.00%+73New
Ameritas Investment Partners, Inc.772$14.0K0.00%00.0%Unchanged
Royal Bank of Canada804$15.0K0.00%−1,459−64.5%Reduced
Allspring Global Investments Holdings, LLC953$17.0K0.00%−144−13.1%Reduced
Legal & General Group Plc1,341$25.0K0.00%+400+42.5%Added
Citigroup Inc1,420$26.0K0.00%−2,048−59.1%Reduced
Tower Research Capital LLC (TRC)1,418$26.0K0.00%−1,706−54.6%Reduced
Wells Fargo & Company1,497$27.0K0.00%−2,973−66.5%Reduced
Amalgamated Bank1,462$27.0K0.00%+1,462New
Amalgamated Financial Corp.1,462$27.0K0.00%+1,462New
STRS Ohio2,300$42.0K0.00%00.0%Unchanged
Bank of America Corp4,103$75.0K0.00%−5,412−56.9%Reduced
Deutsche Bank AG5,446$100.0K0.00%−660−10.8%Reduced
California State Teachers Retirement System5,602$103.0K0.00%−320−5.4%Reduced
Barclays PLC5,787$105.0K0.00%+5,787New
American International Group, Inc.6,494$119.0K0.00%+1,140+21.3%Added
Morgan Stanley7,559$139.0K0.00%−392−4.9%Reduced
JPMorgan Chase & Co9,007$165.0K0.00%+2,995+49.8%Added
Nuveen Asset Management, LLC14,318$209.0K0.00%00.0%Unchanged
New York State Common Retirement Fund12,591$231.0K0.00%+7,821+164.0%Added
Skandinaviska Enskilda Banken AB (publ)14,108$259.0K0.00%+14,108New
Penn Mutual Asset Management, LLC17,458$320.0K0.37%+17,458New
Golden State Equity Partners20,980$385.0K0.19%+5,050+31.7%Added
Bank of New York Mellon Corp30,487$559.0K0.00%+6,674+28.0%Added
Charles Schwab Investment Management Inc32,853$603.0K0.00%+8,117+32.8%Added
Lynx1 Capital Management LP66,977$1.23M1.14%+66,977New
Adage Capital Partners GP, L.L.C.100,000$1.83M0.00%+100,000New
Northern Trust Corp104,450$1.92M0.00%+17,281+19.8%Added
VR Adviser, LLC151,037$2.77M0.45%+151,037New
Fred Alger Management, LLC167,007$3.06M0.01%00.0%Unchanged
State Street Corp168,037$3.08M0.00%+13,813+9.0%Added
Geode Capital Management, LLC195,187$3.58M0.00%+37,457+23.7%Added
Sectoral Asset Management Inc218,913$4.01M0.71%−63,851−22.6%Reduced
Vanguard Group Inc480,110$8.80M0.00%+11,795+2.5%Added
OrbiMed Advisors LLC509,949$9.35M0.15%−25,765−4.8%Reduced
OUP Management Co., LLC603,762$11.1M8.43%00.0%Unchanged
FMR LLC719,474$13.2M0.00%+1,123+0.2%Added
BlackRock Inc.746,934$13.7M0.00%+17,126+2.3%Added
TCG Crossover Management, LLC889,572$16.3M6.55%+36,242+4.2%Added
Citadel Advisors LLC1,593,376$29.2M0.03%−4,103−0.3%Reduced
Cormorant Asset Management, LP1,830,691$33.6M2.58%00.0%Unchanged
Baker Bros. Advisors LP2,070,010$37.9M0.22%+238,221+13.0%Added
Atlas Venture Life Science Advisors, LLC3,103,879$56.9M7.19%00.0%Unchanged
Sofinnova Investments, Inc.3,758,686$68.9M5.79%00.0%Unchanged
Ra Capital Management, L.P.8,263,982$151.5M3.31%00.0%Unchanged
Norges Bank0$00.00%−101,505−100.0%Sold out
Parkwood LLC0$00.00%−37,156−100.0%Sold out
Parametric Portfolio Associates LLC0$00.00%−36,000−100.0%Sold out
HRT Financial LP0$00.00%−34,854−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−18,763−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−15,769−100.0%Sold out
Squarepoint Ops LLC0$00.00%−12,941−100.0%Sold out
Old Well Partners, LLC0$00.00%−12,600−100.0%Sold out
Jane Street Group, LLC0$00.00%−12,415−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−14,849−100.0%Sold out
UBS Group AG0$00.00%−484−100.0%Sold out